Peter Sedgwick
Direktor/Vorstandsmitglied bei 3i Infrastructure (Luxembourg) Holdings SARL
Profil
Peter Sedgwick is currently a Director at 3i Infrastructure (Luxembourg) Holdings SARL and 3i Infrastructure (Luxembourg) SARL.
Previously, he served as the Non-Executive Chairman at 3i Infrastructure Plc from 2009 to 2016.
He also served as the Chairman at Bowel Cancer UK.
Aktive Positionen von Peter Sedgwick
Unternehmen | Position | Beginn |
---|---|---|
3i Infrastructure (Luxembourg) Holdings SARL | Direktor/Vorstandsmitglied | - |
3i Infrastructure (Luxembourg) SARL | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Peter Sedgwick
Unternehmen | Position | Ende |
---|---|---|
3I INFRASTRUCTURE PLC | Vorsitzender | 01.01.2016 |
Bowel Cancer UK
Bowel Cancer UK Investment Trusts/Mutual FundsMiscellaneous Bowel Cancer UK operates as a charity focused on bowel cancer. The non-profit company is based in London, UK. The British company was founded in 1987. Genevieve Edwards has been the CEO of the company since 2020. | Vorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
3i Infrastructure Plc
3i Infrastructure Plc Investment ManagersFinance 3i Infrastructure Plc acts as a private equity fund, which invests in infrastructure businesses and assets in the UK, Europe and North America. The fund focuses on range of investment opportunities across adjacent sectors to utilities, transportation, communications and energy. It provides financing for infrastructure capital requirements. The company was founded on January 16, 2007 and is headquartered in St. Helier, the United Kingdom. | Finance |
3i Infrastructure (Luxembourg) Holdings SARL | |
3i Infrastructure (Luxembourg) SARL | |
Bowel Cancer UK
Bowel Cancer UK Investment Trusts/Mutual FundsMiscellaneous Bowel Cancer UK operates as a charity focused on bowel cancer. The non-profit company is based in London, UK. The British company was founded in 1987. Genevieve Edwards has been the CEO of the company since 2020. | Miscellaneous |